Evidence map›Paper›PMID 24474925›Full record

ArticleCase reports in oncology2013

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event.

Henriette Quack, Luise Erpenbeck, Hendrik A Wolff, Thilo Sprenger, Cornelia S Seitz, Michael P Schön, Steffen Neumann, Kathrin Stanek, B Michael Ghadimi, Beate Michels and 4 more

Registry-linked trialOpen access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03034473 (Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03034473 naunknown statusnot on this map

Translational Validation Study to Examine KFO179-1 Biomarker Scores for the Prediction and Prognosis of Advanced Primary Resectable Rectal Cancer Stages UICC II-IV, With a 5-FU-based Standard Radiochemotherapy Followed by Total Mesorectal Excision.

TypeinterventionalSponsorUniversity Medical Center GoettingenRan2011 to 2024Enrolled200ConditionsLocally Advanced Rectal CancerArmsTranslational Research and multimodal treatment
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Henriette QuackDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
Luise ErpenbeckDepartment of Dermatology, Venereology and Allergology, University Medical Center, Göttingen, Germany ; Immune Disease Institute, Harvard Medical School/Children's Hospital, Boston, Mass., USA.
Hendrik A WolffDepartment of Radiooncology, University Medical Center, Göttingen, Germany.
Thilo SprengerDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
Cornelia S SeitzDepartment of Dermatology, Venereology and Allergology, University Medical Center, Göttingen, Germany.
Michael P SchönDepartment of Dermatology, Venereology and Allergology, University Medical Center, Göttingen, Germany.
Steffen NeumannDepartment of Haematology and Oncology, Klinikum Wolfsburg, Wolfsburg, Germany.
Kathrin StanekDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
B Michael GhadimiDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
Beate MichelsDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
Peter MiddelInstitute for Pathology, University Medical Center, Göttingen, Germany.
Inga-Marie SchaeferInstitute for Pathology, University Medical Center, Göttingen, Germany.
Torsten LierschDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
Lena-Christin ConradiDepartment of General and Visceral Surgery, University Medical Center, Göttingen, Germany.
University of Göttingen · DEUniversitätsmedizin Göttingen · DEFraunhofer Project Centre Wolfsburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukocytoclastic vasculitis is a multicausal systemic inflammatory disease of the small vessels, histologically characterized by inflammation and deposition of both nuclear debris and fibrin in dermal postcapillary venules. The clinical picture typically involves palpable purpura of the lower legs and may be associated with general symptoms such as fatigue, arthralgia and fever. Involvement of the internal organs, most notably the kidneys, the central nervous system or the eyes, is possible and determines the prognosis. Oxaliplatin-induced leukocytoclastic vasculitis is a very rare event that limits treatment options in affected patients. We report 2 patients who developed the condition under chemotherapy for advanced rectal and metastatic colon carcinoma, respectively; a termination of the therapy was therefore necessary. While current therapies for colorectal cancer include the combination of multimodal treatment with new and targeted agents, rare and unusual side effects elicited by established agents also need to be taken into account for the clinical management.

Indexed as

Chemotherapy-associated toxicityColorectal cancerGlomerulonephritisLeukocytoclastic vasculitisOxaliplatin

Identifiers

PMID24474925
PMCPMC3901589
OpenAlexW2102199992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.